BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 38360784)

  • 1.
    Benchoula K; Serpell CJ; Mediani A; Albogami A; Misnan NM; Ismail NH; Parhar IS; Ogawa S; Hwa WE
    Sci Rep; 2024 Feb; 14(1):3823. PubMed ID: 38360784
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combination of high-fat diet-fed and low-dose streptozotocin-treated rat: a model for type 2 diabetes and pharmacological screening.
    Srinivasan K; Viswanad B; Asrat L; Kaul CL; Ramarao P
    Pharmacol Res; 2005 Oct; 52(4):313-20. PubMed ID: 15979893
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biochemical characterization and
    Al-Zuaidy MH; Mumtaz MW; Hamid AA; Ismail A; Mohamed S; Razis AFA
    BMC Complement Altern Med; 2017 Jul; 17(1):359. PubMed ID: 28693595
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effects of liraglutide in mice with diet-induced obesity studied by metabolomics.
    Bugáňová M; Pelantová H; Holubová M; Šedivá B; Maletínská L; Železná B; Kuneš J; Kačer P; Kuzma M; Haluzík M
    J Endocrinol; 2017 Apr; 233(1):93-104. PubMed ID: 28138003
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preventive and ameliorating effects of citrus D-limonene on dyslipidemia and hyperglycemia in mice with high-fat diet-induced obesity.
    Jing L; Zhang Y; Fan S; Gu M; Guan Y; Lu X; Huang C; Zhou Z
    Eur J Pharmacol; 2013 Sep; 715(1-3):46-55. PubMed ID: 23838456
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A murine model of type 2 diabetes mellitus developed using a combination of high fat diet and multiple low doses of streptozotocin treatment mimics the metabolic characteristics of type 2 diabetes mellitus in humans.
    Nath S; Ghosh SK; Choudhury Y
    J Pharmacol Toxicol Methods; 2017; 84():20-30. PubMed ID: 27773844
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Urinary metabolomics study on the protective role of Orthosiphon stamineus in Streptozotocin induced diabetes mellitus in rats via
    Azam AA; Pariyani R; Ismail IS; Ismail A; Khatib A; Abas F; Shaari K
    BMC Complement Altern Med; 2017 May; 17(1):278. PubMed ID: 28545435
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Short-term overfeeding of zebrafish with normal or high-fat diet as a model for the development of metabolically healthy versus unhealthy obesity.
    Landgraf K; Schuster S; Meusel A; Garten A; Riemer T; Schleinitz D; Kiess W; Körner A
    BMC Physiol; 2017 Mar; 17(1):4. PubMed ID: 28327129
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Establishment of type 2 diabetes mellitus models using streptozotocin after 3 months high-fat diet in Bama minipigs.
    Zhao Y; Niu M; Jia Y; Yuan J; Xiang L; Dai X; Wang G; Chen H
    Anim Biotechnol; 2023 Dec; 34(7):2295-2312. PubMed ID: 35749713
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-Term Ingestion of Sicilian Black Bee Chestnut Honey and/or D-Limonene Counteracts Brain Damage Induced by High Fat-Diet in Obese Mice.
    Terzo S; Calvi P; Nuzzo D; Picone P; Allegra M; Mulè F; Amato A
    Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36834882
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolomic analysis and biochemical changes in the urine and serum of streptozotocin-induced normal- and obese-diabetic rats.
    Mediani A; Abas F; Maulidiani M; Abu Bakar Sajak A; Khatib A; Tan CP; Ismail IS; Shaari K; Ismail A; Lajis NH
    J Physiol Biochem; 2018 Aug; 74(3):403-416. PubMed ID: 29766441
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Eburicoic Acid, a Triterpenoid Compound from Antrodia camphorata, Displays Antidiabetic and Antihyperlipidemic Effects in Palmitate-Treated C2C12 Myotubes and in High-Fat Diet-Fed Mice.
    Lin CH; Kuo YH; Shih CC
    Int J Mol Sci; 2017 Nov; 18(11):. PubMed ID: 29099085
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of chronic p,p'-dichlorodiphenyldichloroethylene (DDE) exposure on high fat diet-induced alterations in glucose and lipid metabolism in male C57BL/6H mice.
    Howell GE; Mulligan C; Meek E; Chambers JE
    Toxicology; 2015 Feb; 328():112-22. PubMed ID: 25541407
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pancreastatin inhibitor PSTi8 protects the obesity associated skeletal muscle insulin resistance in diet induced streptozotocin-treated diabetic mice.
    Gupta AP; Garg R; Singh P; Goand UK; Syed AA; Valicherla GR; Riyazuddin M; Mugale MN; Gayen JR
    Eur J Pharmacol; 2020 Aug; 881():173204. PubMed ID: 32439261
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Deacetylepoxyazadiradione ameliorates diabesity in in-vivo zebrafish larval model by influencing the level of regulatory adipokines and oxidative stress.
    Murugan R; Haridevamuthu B; Gopinath P; Rajagopal R; Arokiyaraj S; Arockiaraj J
    Eur J Pharmacol; 2023 Dec; 961():176214. PubMed ID: 37992886
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alginate oligosaccharide (AOS) improves immuno-metabolic systems by inhibiting STOML2 overexpression in high-fat-diet-induced obese zebrafish.
    Tran VC; Cho SY; Kwon J; Kim D
    Food Funct; 2019 Aug; 10(8):4636-4648. PubMed ID: 31290903
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antidiabetic Effect of Salvianolic Acid A on Diabetic Animal Models via AMPK Activation and Mitochondrial Regulation.
    Qiang G; Yang X; Shi L; Zhang H; Chen B; Zhao Y; Zu M; Zhou D; Guo J; Yang H; Zhang L; Du G
    Cell Physiol Biochem; 2015; 36(1):395-408. PubMed ID: 25967977
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Experimental evidence for the use of CCR2 antagonists in the treatment of type 2 diabetes.
    Sullivan TJ; Miao Z; Zhao BN; Ertl LS; Wang Y; Krasinski A; Walters MJ; Powers JP; Dairaghi DJ; Baumgart T; Seitz LC; Berahovich RD; Schall TJ; Jaen JC
    Metabolism; 2013 Nov; 62(11):1623-32. PubMed ID: 23953944
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treating diet-induced diabetes and obesity with human embryonic stem cell-derived pancreatic progenitor cells and antidiabetic drugs.
    Bruin JE; Saber N; Braun N; Fox JK; Mojibian M; Asadi A; Drohan C; O'Dwyer S; Rosman-Balzer DS; Swiss VA; Rezania A; Kieffer TJ
    Stem Cell Reports; 2015 Apr; 4(4):605-20. PubMed ID: 25801507
    [TBL] [Abstract][Full Text] [Related]  

  • 20. (Pro(3))GIP[mPEG]: novel, long-acting, mPEGylated antagonist of gastric inhibitory polypeptide for obesity-diabetes (diabesity) therapy.
    McClean PL; Irwin N; Hunter K; Gault VA; Flatt PR
    Br J Pharmacol; 2008 Nov; 155(5):690-701. PubMed ID: 18695644
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.